Updates in the Patient Journey: Autoimmune Hepatitis and Primary Sclerosing Cholangitis 

Nov 15 2024
Convention Center: Ballroom 20 A
12:30 PM - 2:00 PM

World Class Speakers

Craig Lammert, MD
Industry Presenter

Craig Lammert, MD

Indiana University
John M Vierling, MD, FACP, FAASLD, AGAF
Industry Presenter

John M Vierling, MD, FACP, FAASLD, AGAF

Baylor College of Medicine
Cynthia Buness
Industry Presenter

Cynthia Buness

Description

This is an update on autoimmune liver disease, in particular AIH and PSC. There is a focus on the current evidence-base around precision markers and NITs in diagnosing, monitoring and prognosticating autoimmune disease and new treatments on the horizon. Finally, we explore how patient advocate groups can help inform PROMS and approaches to research. 

Supported By: Perspectum Ltd 

Organizer: HealthProMatch

For more information and to register, visit: https://healthpromatch.com/cme-event-nov-15/

Objectives

  • Describe and understand the revised classification and available decision-aids in immune- mediated liver disease, in particular AIH and PSC
  • Critically appraise current evidence-base for precision markers in blood tests and imaging for diagnosis, monitoring and prognosticating in patients with autoimmune liver disease
  • Reflect upon patient narratives and suggestions from patient advocate groups regarding treatment strategies and approaches to research.